Neurogene Inc.
NGNEBiotechnology
$27.55−4.41%As of Oct 30vs prior close
- Market cap
- $551.3M
- P/E (TTM)
- –
- From 52W high
- −35.69%
- EPS (YE25)
- -$4.24
- Revenue (YE25)
- $0
- Dividend yield
- 0.00%
Nomior Score
34
Steady ProfileBottom 20% of the scored universe
Growth—
Quality48
Value46
Momentum33
Resilience31
Growth
$0revenue, YE25
YE18 $25MYE25 $0
Connections
Revenue to profitYE24
The operating loss was 8930% of revenue.
Who owns it
2funds